Literature DB >> 31941653

Paraneoplastic leukemoid reactions induced by cytokine-secreting tumours.

Ibrahim A Abukhiran1, Judy Jasser2, Sergei Syrbu2.   

Abstract

Paraneoplastic leukemoid reaction (PLR) is the extreme leukocytosis that occurs due to a non-haematolymphoid cytokine-secreting tumour (CST) in the absence of bone marrow infiltration by that solid tumour. The clinical presentation is widely variable, and therefore challenging. If the underlying malignancy is not clinically apparent, PLR could be mistaken for myeloproliferative neoplasms, altering the patient's management. CSTs are highly aggressive tumours associated with a poor prognosis due to multiple mechanisms. Localising and treating the underlying malignancy is the mainstay of treatment. Both the treating clinician and the pathologist should keep a high level of suspicion for this entity in patients having unexplained leukocytosis. We herein discuss the underlying mechanisms, clinical presentation, pathological features, differential diagnosis and prognosis of this rare entity. An emphasis on the role of the pathologist is provided since the lack of knowledge on this entity can lead to dramatic effects on the patient, including unnecessary diagnostic testing and treatments. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cancer; chronic myeloid leukaemia; cytokines; leukocytes

Year:  2020        PMID: 31941653     DOI: 10.1136/jclinpath-2019-206340

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  Cytokine alterations during paraneoplastic neutrophilia and leukemoid reaction in patients with advanced melanoma.

Authors:  Xin-Wen Zhang; Alexander Wald; Martin Salzmann; Niels Halama; Jessica C Hassel
Journal:  Cancer Immunol Immunother       Date:  2022-07-16       Impact factor: 6.630

2.  Thymus Subset Alterations Accompanying Concomitant Tumor Immunity Mimics Phenotypic Patterns of Cytotoxic Drug Doxorubicin.

Authors:  Gintaras Zaleskis; Dainius Characiejus; Jurgita Jursenaite; Lavija Zibutyte; Karolina Kriauciunaite; Milda Vanagaite-Zickiene; Adas Darinskas; Mantas Jonusis; Vita Pasukoniene
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

3.  Be(a)ware of Leukocytosis in Papillary Thyroid Cancer.

Authors:  Styliani Laskou; Konstantinos Sapalidis; Christos Topalidis; Triantafyllia Koletsa; Isaak Kesisoglou
Journal:  Case Rep Endocrinol       Date:  2022-07-16

Review 4.  Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report.

Authors:  Clelia Madeddu; Elisabetta Sanna; Sonia Nemolato; Olga Mulas; Sara Oppi; Mario Scartozzi; Giorgio La Nasa; Antonio Maccio
Journal:  Diagnostics (Basel)       Date:  2022-08-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.